Neurology · Denver area, CO
Neurology studies in Denver area, CO
54 recruiting studies have a site in the Denver area. This page includes nearby cities such as Aurora, Lakewood, Englewood, Littleton.
54 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Aurora, CO + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- Aurora, CO + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Novartis Pharmaceuticals
- Location
- Englewood, CO + 39 other US sites
- Eligibility basics
- Ages 21–70
- RecruitingPhase 2/Phase 3
A Study of Buntanetap in Participants With PD
Annovis Bio Inc.
- Location
- Englewood, CO + 26 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 1/Phase 2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
AbbVie
- Location
- Boulder, CO + 10 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Aurora, CO + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Dompé Farmaceutici S.p.A
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Centennial, CO + 111 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Aurora, CO + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Aurora, CO + 33 other US sites
- Eligibility basics
- Ages 45–75
- RecruitingPhase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines
- Location
- Aurora, CO + 5 other US sites
- Eligibility basics
- Ages 0 mo–18
- Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W.L.Gore & Associates
- Location
- Littleton, CO + 30 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Boulder, CO + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Aurora, CO + 34 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Use of CereGate Therapy for Freezing of Gait in PD
CereGate Inc.
- Location
- Aurora, CO + 6 other US sites
- Eligibility basics
- Ages 21–80
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Neurona Therapeutics
- Location
- Aurora, CO + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Michael Shy
- Location
- Aurora, CO + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
University of Iowa
- Location
- Aurora, CO + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Mayo Clinic
- Location
- Denver, CO + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
ASSESS ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Aurora, CO + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
PREVENT ALL ALS Study
St. Joseph's Hospital and Medical Center, Phoenix
- Location
- Aurora, CO + 30 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
VA Office of Research and Development
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 40+
- RecruitingHealthy volunteers
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Michael J. Fox Foundation for Parkinson's Research
- Location
- Aurora, CO + 29 other US sites
- Eligibility basics
- Ages 30+
- RecruitingHealthy volunteers
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
University College, London
- Location
- Englewood, CO + 4 other US sites
- Eligibility basics
- Ages 11–75
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.